Catalyst Oncology

Cancer and Oncology News

Catalyst Oncology header image 2

Lung Cancer Study of Novel Oral Drug Sapacitabine at CORT « Center …

January 28th, 2009 · No Comments

Center for Oncology Research & Treatment–Dallas, TX. Innovative Cancer Treatment. « Sequential Therapies and Integration of Investigational Agents in Treatment of Metastatic Cancer. Lung Cancer Study of Novel Oral Drug Sapacitabine at …

Excerpt from:
Lung Cancer Study of Novel Oral Drug Sapacitabine at CORT « Center …

Tags: oncology · oncology cancer

0 responses so far ↓

  • There are no comments yet...Kick things off by filling out the form below.

You must log in to post a comment.